Starpharma Holdings Limited logo

Starpharma Holdings Limited

ASX:SPL.AX

Overview | Financials
Company Name Starpharma Holdings Limited
Symbol SPL.AX
Currency AUD
Price 0.098
Market Cap 40,902,064
Dividend Yield 0%
52-week-range 0.086 - 0.195
Industry Biotechnology
Sector Healthcare
CEO Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), GAICD, MBA
Website https://starpharma.com

An error occurred while fetching data.

About Starpharma Holdings Limited

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral

Related Stocks

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.955 AUD

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.49 AUD

Immutep Limited logo

Immutep Limited

IMM.AX

0.345 AUD

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.7 AUD

Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

PAR.AX

0.245 AUD

Capitol Health Limited logo

Capitol Health Limited

CAJ.AX

0.32 AUD

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.855 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.06 AUD

Trajan Group Holdings Limited logo

Trajan Group Holdings Limited

TRJ.AX

1.19 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD